CLOV Sale Disclosure
Reynoso Jamie L. · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$9.29K
Reynoso Jamie L. CEO, Medicare Advantage
CLOV
Transaction date
Oct 7, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed same day
CLOV daily price context
Close on/before transaction
$4.56
Oct 7, 2026
First close after public filing
$4.58
Oct 8, 2026
Return after filing · so far
+4.59%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 2,006 shares @ $4.63
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001839066-26-000054
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$9.29K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Clover Health Investments, Corp. /de CLOV Current | Sale | Oct 7, 2026 | $9.29K |